Legis Daily

Essential Medicines Strategic Stockpile Act of 2020

USA116th CongressHR-8479| House 
| Updated: 10/1/2020
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Lisa Blunt Rochester (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Essential Medicines Strategic Stockpile Act of 2020 This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 1, 2020
Introduced in House
Oct 1, 2020
Referred to the House Committee on Energy and Commerce.
  • October 1, 2020
    Introduced in House


  • October 1, 2020
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • HR 116-14: Commitment to Defeat the Virus and Keep America Healthy Act
Business recordsCongressional oversightEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesPrescription drugsPublic contracts and procurementPublic-private cooperationStrategic materials and reserves

Essential Medicines Strategic Stockpile Act of 2020

USA116th CongressHR-8479| House 
| Updated: 10/1/2020
Essential Medicines Strategic Stockpile Act of 2020 This bill requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 1, 2020
Introduced in House
Oct 1, 2020
Referred to the House Committee on Energy and Commerce.
  • October 1, 2020
    Introduced in House


  • October 1, 2020
    Referred to the House Committee on Energy and Commerce.
Earl L. "Buddy" Carter

Earl L. "Buddy" Carter

Republican Representative

Georgia

Cosponsors (1)
Lisa Blunt Rochester (Democratic)

Energy and Commerce Committee

Health

Related Bills

  • HR 116-14: Commitment to Defeat the Virus and Keep America Healthy Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsCongressional oversightEmergency medical services and trauma careGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesPrescription drugsPublic contracts and procurementPublic-private cooperationStrategic materials and reserves